Susan Mesco | Head, IR |
Dave Stack | Chairman, CEO |
Charlie Reinhart | CFO |
David Amsellem | Piper Sandler |
Chris Neyor | JP Morgan |
Balaji Prasad | Barclays |
Gregory Renza | RBC Capital Markets |
Greg Fraser | Truist Securities |
Serge Belanger | Needham |
Ladies and gentlemen, thank you for standing by, and welcome to the Pacira BioScience's Second Quarter 2022 Earnings Call. [Operator Instructions] I would now like to turn the call over to Susan Mesco, Head of Investor Relations. Please go ahead.
Thank you, Paula, and good morning, everyone. Welcome to today's conference call to discuss our second quarter 2022 financial results.